Thermo Fisher Scientific reports $44.56 billion revenue for fiscal year ended December 31, 2025, up 3.9%
Thermo Fisher Scientific reported revenue of $44.56 billion for the year ended December 31, 2025, an increase of 3.9% from the previous year ($42.88 billion).
For the same period it posted net income of $6.7 billion, up 5.8%, or $17.74 per diluted share (16.53 a year earlier).
That is a net margin of 15%.
On Sanad's AAOIFI Standard 21 screen, Thermo Fisher Scientific is currently compliant: interest-bearing debt is 16.3% of market capitalisation (limit 30%), and impure income is 2.2% of revenue (limit 5%).
Is Thermo Fisher Scientific halal?
See the full AAOIFI screening of Thermo Fisher Scientific
See the full AAOIFI screening of Thermo Fisher Scientific
Source: 10-K filed with the U.S. Securities and Exchange Commission on February 26, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.